AAPS 2017 Poster: Development of a Modified Release Tablet Containing an API Prone to Form Changes and Gelling in Aqueous Media
13 November 2017
Overview
Development of an MR formulation of Cmp-1 was planned using RapidFACT®: an integrated approach that allows formulation optimization based on human PK data with an adaptive clinical design. Selection of a discriminatory in vitro dissolution test was an important early development activity.
Request a copy of our poster, 'Development of a Modified Release Tablet Containing an API Prone to Form Changes and Gelling in Aqueous Media.'